Bausch Health Companies Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Bausch Health Companies Inc. (BHC) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$9.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-07-30
- Bausch Health Companies Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$36.00M.
- Bausch Health Companies Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $27.00M, a 41.30% decline year-over-year.
- Bausch Health Companies Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$32.00M.
- Bausch Health Companies Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$5.00M.
- Bausch Health Companies Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$3.00M.
- Bausch Health Companies Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$133.00M, a 159.64% decline from fiscal 2023.
- Bausch Health Companies Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $223.00M, a 237.88% increase from fiscal 2022.
- Bausch Health Companies Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $66.00M, a 1550.00% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$36.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$9.00M 10-Q · filed 2026-07-30 | -$41.00M derived: sum of 3 quarters · filed 2026-07-30 | -$46.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $27.00M 10-Q · filed 2026-04-30 | -$5.00M derived: sum of 2 quarters · filed 2026-04-30 | -$10.00M derived: sum of 3 quarters · filed 2026-04-30 | -$22.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | -$32.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$37.00M derived: sum of 2 quarters · filed 2026-02-19 | -$49.00M derived: sum of 3 quarters · filed 2026-07-30 | -$3.00M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$17.00M derived: sum of 2 quarters · filed 2026-07-30 | $29.00M 10-Q · filed 2025-10-30 | $16.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | -$12.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $34.00M 10-Q · filed 2026-07-30 | $21.00M derived: sum of 3 quarters · filed 2026-07-30 | $20.00M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $46.00M 10-Q · filed 2026-04-30 | $33.00M derived: sum of 2 quarters · filed 2026-04-30 | $32.00M derived: sum of 3 quarters · filed 2026-04-30 | $34.00M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-12-31 | -$13.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$14.00M derived: sum of 2 quarters · filed 2026-02-19 | -$12.00M derived: sum of 3 quarters · filed 2026-02-19 | -$133.00M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.00M derived: sum of 2 quarters · filed 2025-10-30 | -$120.00M 10-Q · filed 2025-10-30 | $28.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$119.00M 10-Q · filed 2025-07-31 | $29.00M derived: sum of 3 quarters · filed 2026-02-19 | $50.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | -$121.00M 10-Q · filed 2025-05-01 | $27.00M derived: sum of 2 quarters · filed 2026-02-19 | $48.00M derived: sum of 3 quarters · filed 2026-02-19 | $69.00M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | $148.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $169.00M derived: sum of 2 quarters · filed 2026-02-19 | $190.00M derived: sum of 3 quarters · filed 2026-02-19 | $223.00M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $21.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $42.00M derived: sum of 2 quarters · filed 2024-10-31 | $75.00M 10-Q · filed 2024-10-31 | $109.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $54.00M 10-Q · filed 2024-08-01 | $88.00M derived: sum of 3 quarters · filed 2025-02-20 | $72.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2023-03-31 | $33.00M 10-Q · filed 2024-05-02 | $67.00M derived: sum of 2 quarters · filed 2025-02-20 | $51.00M derived: sum of 3 quarters · filed 2025-02-20 | $66.00M derived: sum of 4 quarters · filed 2025-02-20 | ||||
| 2022-12-31 | $34.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $18.00M derived: sum of 2 quarters · filed 2025-02-20 | $33.00M derived: sum of 3 quarters · filed 2025-02-20 | $66.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | -$16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$1.00M derived: sum of 2 quarters · filed 2023-11-02 | $32.00M 10-Q · filed 2023-11-02 | $73.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-06-30 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $48.00M 10-Q · filed 2023-08-03 | $89.00M derived: sum of 3 quarters · filed 2024-02-22 | $73.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-03-31 | $33.00M 10-Q · filed 2023-05-04 | $74.00M derived: sum of 2 quarters · filed 2024-02-22 | $58.00M derived: sum of 3 quarters · filed 2024-02-22 | $37.00M derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $41.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $25.00M derived: sum of 2 quarters · filed 2024-02-22 | $4.00M derived: sum of 3 quarters · filed 2024-02-22 | $4.00M 10-K · filed 2024-02-22 | ||||
| 2021-09-30 | -$16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$37.00M derived: sum of 2 quarters · filed 2022-11-03 | -$37.00M 10-Q · filed 2022-11-03 | -$38.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-06-30 | -$21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$21.00M 10-Q · filed 2022-08-09 | -$22.00M derived: sum of 3 quarters · filed 2023-02-23 | -$49.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | -$1.00M derived: sum of 2 quarters · filed 2023-02-23 | -$28.00M derived: sum of 3 quarters · filed 2023-02-23 | -$30.00M derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$28.00M derived: sum of 2 quarters · filed 2023-02-23 | -$30.00M derived: sum of 3 quarters · filed 2023-02-23 | -$12.00M 10-K · filed 2023-02-23 | ||||
| 2020-09-30 | -$27.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$29.00M derived: sum of 2 quarters · filed 2021-11-02 | -$11.00M 10-Q · filed 2021-11-02 | $4.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $16.00M 10-Q · filed 2021-08-03 | $31.00M derived: sum of 3 quarters · filed 2022-05-11 | $16.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | $18.00M 10-Q · filed 2021-05-04 | $33.00M derived: sum of 2 quarters · filed 2022-05-11 | $18.00M derived: sum of 3 quarters · filed 2022-05-11 | $2.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | $15.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $0.00 derived: sum of 2 quarters · filed 2022-05-11 | -$16.00M derived: sum of 3 quarters · filed 2022-05-11 | -$1.00M 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | -$15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$31.00M derived: sum of 2 quarters · filed 2020-11-03 | -$16.00M 10-Q · filed 2020-11-03 | $3.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-06-30 | -$16.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$1.00M 10-Q · filed 2020-08-06 | $18.00M derived: sum of 3 quarters · filed 2021-05-04 | -$5.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | $15.00M 10-Q · filed 2020-05-07 | $34.00M derived: sum of 2 quarters · filed 2021-05-04 | $11.00M derived: sum of 3 quarters · filed 2021-05-04 | $17.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | $19.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | -$4.00M derived: sum of 2 quarters · filed 2021-05-04 | $2.00M derived: sum of 3 quarters · filed 2021-05-04 | $72.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | -$23.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$17.00M derived: sum of 2 quarters · filed 2019-11-04 | $53.00M 10-Q · filed 2019-11-04 | $52.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $76.00M 10-Q · filed 2019-08-06 | $75.00M derived: sum of 3 quarters · filed 2020-02-19 | $63.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $70.00M 10-Q · filed 2019-05-06 | $69.00M derived: sum of 2 quarters · filed 2020-02-19 | $57.00M derived: sum of 3 quarters · filed 2020-02-19 | $39.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$13.00M derived: sum of 2 quarters · filed 2020-02-19 | -$31.00M derived: sum of 3 quarters · filed 2020-02-19 | -$33.00M 10-K · filed 2020-02-19 | ||||
| 2017-09-30 | -$12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$30.00M derived: sum of 2 quarters · filed 2018-11-06 | -$32.00M 10-Q · filed 2018-11-06 | -$146.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | -$18.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$20.00M 10-Q · filed 2018-08-07 | -$134.00M derived: sum of 3 quarters · filed 2019-02-20 | -$90.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | -$2.00M 10-Q · filed 2018-05-08 | -$116.00M derived: sum of 2 quarters · filed 2019-02-20 | -$72.00M derived: sum of 3 quarters · filed 2019-02-20 | -$77.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | -$114.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$70.00M derived: sum of 2 quarters · filed 2019-02-20 | -$75.00M derived: sum of 3 quarters · filed 2019-02-20 | -$232.00M 10-K · filed 2019-02-20 | ||||
| 2016-09-30 | $44.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $39.00M derived: sum of 2 quarters · filed 2017-11-07 | -$118.00M 10-Q · filed 2017-11-07 | -$117.70M 10-Q · filed 2016-11-09 | -$279.00M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$162.00M 10-Q · filed 2017-08-08 | -$161.70M 10-Q · filed 2016-08-09 | -$323.00M derived: sum of 3 quarters · filed 2018-08-10 | -$234.50M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | -$157.00M 10-Q · filed 2017-05-09 | -$156.50M 10-Q · filed 2016-06-07 | -$318.00M derived: sum of 2 quarters · filed 2018-08-10 | -$229.50M derived: sum of 3 quarters · filed 2018-08-10 | -$111.10M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | -$161.00M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | -$72.50M derived: sum of 2 quarters · filed 2018-08-10 | $45.90M derived: sum of 3 quarters · filed 2018-08-10 | $91.00M 8-K · filed 2018-08-10 | $90.60M 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $88.50M 10-Q · filed 2015-10-26 | $206.90M derived: sum of 2 quarters · filed 2015-10-26 | $252.00M 10-Q · filed 2016-11-09 | $396.50M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $118.40M 10-Q · filed 2015-07-28 | $163.50M 10-Q · filed 2016-08-09 | $308.00M derived: sum of 3 quarters · filed 2017-03-01 | $302.50M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $45.10M 10-Q · filed 2016-06-07 | $189.60M derived: sum of 2 quarters · filed 2017-03-01 | $184.10M derived: sum of 3 quarters · filed 2017-03-01 | $159.30M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $144.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $139.00M derived: sum of 2 quarters · filed 2017-03-01 | $114.20M derived: sum of 3 quarters · filed 2017-03-01 | $110.00M 10-K · filed 2017-03-01 | $110.30M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | -$5.50M 10-Q · filed 2015-10-26 | -$30.30M derived: sum of 2 quarters · filed 2015-10-26 | -$34.50M 10-Q · filed 2015-10-26 | -$75.80M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | -$24.80M 10-Q · filed 2015-07-28 | -$29.00M 10-Q · filed 2015-07-28 | -$70.30M derived: sum of 3 quarters · filed 2016-04-29 | -$118.30M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | -$4.20M 10-Q · filed 2015-04-30 | -$45.50M derived: sum of 2 quarters · filed 2016-04-29 | -$93.50M derived: sum of 3 quarters · filed 2016-04-29 | -$103.40M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | -$41.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | -$89.30M derived: sum of 2 quarters · filed 2016-04-29 | -$99.20M derived: sum of 3 quarters · filed 2016-04-29 | -$121.50M 10-K · filed 2016-04-29 | -$82.34M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | -$48.00M 10-Q · filed 2014-10-24 | -$49.79M 10-Q · filed 2013-11-01 | -$57.90M derived: sum of 2 quarters · filed 2014-10-24 | -$80.20M 10-Q · filed 2014-10-24 | -$55.02M 10-Q · filed 2013-11-01 | -$100.86M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | -$9.90M 10-Q · filed 2014-08-01 | -$5.35M 10-Q · filed 2013-08-07 | -$32.20M 10-Q · filed 2014-08-01 | -$5.23M 10-Q · filed 2013-08-07 | -$52.86M derived: sum of 3 quarters · filed 2015-02-25 | -$46.53M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | -$22.30M 10-Q · filed 2014-05-09 | $122.00K 10-Q · filed 2013-05-03 | -$42.96M derived: sum of 2 quarters · filed 2015-02-25 | -$36.63M derived: sum of 3 quarters · filed 2015-02-25 | -$37.77M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | -$20.66M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | -$14.33M derived: sum of 2 quarters · filed 2015-02-25 | -$15.47M derived: sum of 3 quarters · filed 2015-02-25 | -$11.20M 10-K · filed 2015-02-25 | -$54.83M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $6.32M 10-Q · filed 2013-11-01 | $5.19M derived: sum of 2 quarters · filed 2013-11-01 | $9.46M 10-Q · filed 2013-11-01 | $10.36M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | -$1.13M 10-Q · filed 2013-08-07 | $3.13M 10-Q · filed 2013-08-07 | $4.03M derived: sum of 3 quarters · filed 2014-02-28 | $11.84M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $4.27M 10-Q · filed 2013-05-03 | $5.16M derived: sum of 2 quarters · filed 2014-02-28 | $12.98M derived: sum of 3 quarters · filed 2014-02-28 | $480.00K derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $898.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $8.71M derived: sum of 2 quarters · filed 2014-02-28 | -$3.79M derived: sum of 3 quarters · filed 2014-02-28 | $3.08M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $7.81M 10-Q · filed 2012-11-05 | -$4.68M derived: sum of 2 quarters · filed 2012-11-05 | $2.19M 10-Q · filed 2012-11-05 | -$2.14M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | -$12.50M 10-Q · filed 2012-08-03 | -$5.63M 10-Q · filed 2012-08-03 | -$9.95M derived: sum of 3 quarters · filed 2013-02-28 | -$7.79M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $6.87M 10-Q · filed 2012-05-04 | $2.55M derived: sum of 2 quarters · filed 2013-02-28 | $4.71M derived: sum of 3 quarters · filed 2013-02-28 | $1.75M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | -$4.32M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$2.16M derived: sum of 2 quarters · filed 2013-02-28 | -$5.12M derived: sum of 3 quarters · filed 2013-02-28 | -$7.39M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $2.16M 10-Q · filed 2011-11-04 | -$797.00K derived: sum of 2 quarters · filed 2011-11-04 | -$3.07M 10-Q · filed 2011-11-04 | -$2.38M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | -$2.96M 10-Q · filed 2011-08-08 | -$5.24M 10-Q · filed 2011-08-08 | -$4.54M derived: sum of 3 quarters · filed 2012-02-29 | $1.54M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | -$2.27M 10-Q · filed 2011-05-10 | -$1.58M derived: sum of 2 quarters · filed 2012-02-29 | $4.50M derived: sum of 3 quarters · filed 2012-02-29 | $1.73M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $691.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $6.78M derived: sum of 2 quarters · filed 2012-02-29 | $4.01M derived: sum of 3 quarters · filed 2012-02-29 | $796.00K 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $6.08M 10-Q · filed 2010-11-05 | $3.31M derived: sum of 2 quarters · filed 2010-11-05 | $105.00K 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | -$2.77M 10-Q · filed 2010-08-06 | -$5.98M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | -$318.00K 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |